Trump unveils 100 percent tariff on drugs to push for pharmaceutical deals
US President Donald Trump has signed an executive order imposing up to 100% tariffs on patented pharmaceuticals imported into the US, aiming to bring manufacturing home and lower drug prices. Companies that move operations to the US or agree to pricing deals can see reduced or zero tariffs. Australia has resisted pressure to change its drug pricing scheme, while countries like the UK, EU, Japan, and South Korea have negotiated lower rates.